Table 4.

Summary of adverse events by type and study period.

SOC Preferred Term	Adverse Events 4-Weeks (n)	(%)a	Adverse Events Follow up (n)	(%)b
Patients	64		60
Patients who Experienced Adverse Events	32	50.0	16	26.6
Palpitations	4	6.3	0	0
Abdominal Pain Upper	3	4.7	3	4.9
Diarrhea	4	6.3	2	3.3
Dyspepsia	7	10.9	0	0
Gastrointestinal Pain	10	15.6	3	4.9
Nausea	13	20.3	8	13.1
Vomiting	7	10.9	2	3.3
Asthenia	2	3.1	2	3.3
Fatigue	8	12.5	9	14.8
Pain	4	6.3	0	0
Headache	8	12.5	6	9.8
Tremor	4	6.3	1	1.6
Insomnia	4	6.3	2	3.3
Irritability	1	1.6	3	4.9
Hyperhidrosis	8	12.5	3	4.9
Rash	2	3.1	2	3.3

a: Percentage based on all 64 patients. b: Percentage based on the 60 patients who were treated with Suboxone during the follow-up period.